Polyamines regulate expression of the neoplastic phenotype in mouse skin

Cancer Research

Volumn 58, Issue 8, 1998, Pages 1654-1659

  Soler, Alejandro Peralta ^a   Gilliard, Gwendolyn ^a   Megosh, Louis ^a   George, Kenneth ^a   O'Brien, Thomas G ^a  

^a LANKENAU INSTITUTE FOR MEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; EFLORNITHINE; POLYAMINE;

ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL PROLIFERATION; ENZYME ACTIVITY; ENZYME ANALYSIS; MOUSE; NEWBORN; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SKIN CANCER;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; CARCINOMA, PAPILLARY; CARCINOMA, SQUAMOUS CELL; CELL TRANSFORMATION, NEOPLASTIC; EFLORNITHINE; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, NEOPLASTIC; KERATINOCYTES; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; ORNITHINE DECARBOXYLASE; POLYAMINES; PUTRESCINE; SKIN; SKIN NEOPLASMS; SPERMIDINE; SPERMINE;

EID: 0032522797     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. O'Brien, T. G., Megosh, L. C., Gilliard, G., and Peralta Soler, A. Ornithine decarboxylase overexpression is a sufficient condition for tumor promotion in mouse skin. Cancer Res., 57: 2630-2637, 1997.
2. O'Brien, T. G., Simsiman, R. C., and Boutwell, R. K. Induction of the polyamine biosynthetic enzymes in mouse epidermis and their specificity for tumor promotion. Cancer Res., 35: 2426-2433, 1975.
3. Kruszewski, R. H., Chenicek, K. J., and DiGiovanni, J. Effect of application frequency on epidermal omithine decarboxylase induction by chrysarobin in SENCAR mice. Cancer Lett., 32: 263-269, 1986.
4. Koza, R. A., Megosh, L. C., Palmieri, M., and O'Brien, T. G. Constitutively elevated levels of ornithine and polyamines in mouse epidermal papillomas. Carcinogenesis (Lond.), 12: 1619-1625, 1991.
5. O'Brien, T. G., O'Donnell, K., Kruszewski, F. H., and DiGiovanni, J. Presence of a functionally altered ornithine decarboxylase activity in chrysarobin-promoted mouse epidermal papillomas. Carcinogenesis (Lond.), 9: 2081-2085, 1988.
6. Metcalf, R., Bey, P., Danzin, C., Jung, M. J., Casara, P., and Vevert, J. P. Catalytic irreversible inhibition of mammalian ornithine decarboxylase (E.C. 4.1.1.17) by substrate and produce analogues. J. Am. Chem. Soc., 100: 2551-2553, 1978.
7. Peralta Soler, A., Gilliard, G., Megosh, L. C., and O'Brien, T. G. Modulation of murine hair follicle function by alterations in ornithine decarboxylase activity. J. Invest. Dermatol., 106: 1108-1113, 1996.
8. Homma, Y., Kakizoe, T., Samma, S., and Oyasu, R. Inhibition of N-butyl-N-(4-hydroxybutyl)nitrosamine-induced rat urinary bladder carcinogenesis by α-difluoromethylornithine. Cancer Res., 47: 6176-6179, 1987.
9. Kingsworth, A. N., King, W. W. K., Diekema, K. A., McCann, P. P., Ross, J. S., and Malt, R. A. Inhibition of ornithine decarboxylase with 2-difluoromethylornithine: reduced incidence of dimethylhydrazine-induced colon tumors in mice. Cancer Res., 43: 2545-2549, 1983.
10. Thompson, H. J., Herbst, E. J., Meeker, L. D., Minocha, R., Ronan, A. M., and Fite, R. Effect of D,L-α-difluoromethylornithine on murine mammary carcinogenesis. Carcinogenesis (Lond.), 5: 1649-1651, 1984.
11. Takigawa, M., Verma, A. K., Simsiman, R. C., and Boutwell, R. K. Polyamine biosynthesis and skin tumor promotion: inhibition of 12-O-tetradecanoyl-phorbol-13-acetate-promoted mouse skin tumor formation by the irreversible inhibitor of ornithine decarboxylase α-difluoromethylornithine. Biochem. Biophys. Res. Commun., 105: 969-976, 1982.
12. Benrezzak, O., Nigam, V. N., and Madarnas, P. Increased survival of CD1 mice bearing dimethylhydrazine induced primary colon and anal cancers by difluoromethylornithine with concomittant increase in angiosarcoma incidence. Anticancer Res., 7: 251-258, 1987.
13. Shaw, M. W., Guinan, P. D., McKiel, C. F., Dubin, A., and Rubenstein, M. Combination therapy using polyamine synthesis inhibitor α-difluoromethylornithine and Adriamycin in treatment of rats carrying the Dunning R3327 MAT-LyLu prostatic adenocarcinoma. Prostate, 11: 87-93, 1987.
14. Ajani, J. A., Ota, D. M., Grossie, V. B., Jr., Abbruzzese, J. L., Faintuch, J. S., Patt, Y. Z., Jackson, D. E., Levin, B., and Nishioka, K. Evaluation of continuous-infusion α-difluoromethylornithine therapy for colorectal carcinoma. Cancer Chemother. Pharmacol., 26: 223-226, 1990.
15. Megosh, L., Gilmour, S. K., Rosson, D., Peralta Soler, A., Blessing, M., Sawicki, J. A., and O'Brien, T. G. Increased frequency of spontaneous skin tumors in transgenic mice which overexpress omithine decarboxylase. Cancer Res., 55: 4205-4209, 1995.
16. O'Brien, T. G., and Diamond, L. Ornithine decarboxylase induction and DNA synthesis in hamster embryo cell cultures treated with tumor-promoting phorbol diesters. Cancer Res., 37: 3895-3900, 1977.
17. O'Brien, T. G. The induction of ornithine decarboxylase as an early, possibly obligatory event in mouse skin carcinogenesis. Cancer Res., 36: 2644-2653, 1976.
18. Weeks, C. E., Herrmann, A. L., Nelson, F. R., and Slaga, T. J. α-Difluoromethylornithine, an irreversible inhibitor of omithine decarboxylase, inhibits tumor promoter-induced polyamine accumulation and carcinogenesis in mouse skin. Proc. Natl. Acad. Sci. USA, 79: 6028-6032, 1982.
19. Bailleul, B., Surani, M. A., White, S., Barton, S. C., Brown, K., Blessing, M., Jorcano, J., and Balmain, A. Skin hyperkeratosis and papilloma formation in transgenic mice expressing a ras oncogene from a suprabasal keratin promoter. Cell, 62: 697-708, 1990.
20. Blessing, M., Nanney, L. B., King, L. E., Jones, C. M., and Hogan, B. L. M. Transgenic mice as a model to study the role of TGF-β-related molecules in hair follicles. Genes Dev., 7: 204-215, 1992.
21. Vassar, R., Rosenberg, M., Ross, S., Tyner, A., and Fuchs, E. Tissue-specific and differentiation-specific expression of a human K14 keratin gene in transgenic mice. Proc. Natl. Acad. Sci. USA, 86: 1563-1567, 1989.
22. Luk, G. D., Abeloff, M. D., Griffin, C. A., and Baylin, S. B. Successful treatment with DL-α-difluoromethylornithine in established human small cell variant lung carcinoma implants in athymic mice. Cancer Res., 43: 4239-4243, 1983.
23. Zhang, S-Z., Luk, G. D., and Hamilton, S. R. α-Difluoromethylornithine-induced inhibition of growth of autochthonous experimental colonic tumors produced by azoxymethane in male F344 rats. Cancer Res., 48: 6498-6503, 1988.
24. Upp, J. R., Jr., Beauchamp, R. D., Townsend, C. M., Jr., Barranco, S. C., Singh, P., Rajaraman, S., James, E., and Thompson, J. C. Inhibition of human gastric adenocarcinoma xenograft growth in nude mice by α-difluoromethylornithine. Cancer Res., 48: 3265-3269, 1988.
25. Pegg, A. E. Polyamine metabolism and its importance in neoplastic growth and as a target for chemotherapy. Cancer Res., 48: 759-774, 1988.
26. Bizub, D., Wood, A. W., and Shalka, A. M. Mutagenesis of the Ha-ras oncogene in mouse skin tumours induced by polycyclic aromatic hydrocarbons. Proc. Natl. Acad. Sci. USA, 83: 6048-6052, 1986.
27. Quintanilla, M., Brown, K., Ramsden, M., and Balmain, A. Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis. Nature (Lond.), 322: 78-80, 1986.
28. Barbacid, M. ras genes. Annu. Rev. Biochem., 56: 779-827, 1987.
29. Vogelstein, B., Fearon, E. R., Hamilton, S. R., Kern, S. E., Preisinger, A. C., Leppert, M., Nakumura, Y., White, R., Smits, A. M. M., and Bos, J. L. Genetic alterations during colorectal-tumor development. N. Engl. J. Med., 319: 525-532, 1988.